Heterocyclic compounds and their preparation and use
CA 2127251 A1 · Owner: Novo Nordisk A/S · Inventors: Sauerberg, Per; Olesen, Preben H.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds of formula (I) wherein X and Z independently are oxygen or sulfur; and G is independently selected from the group of azacyclic or azabicyclic ring systems consisting of a and b wherein the oxadiazole or thiadiazole ring can be attached at any position. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 7, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 7, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 7, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.